New medicines agreement aims to tackle chronic supply crisis across bloc with public funding support.
ℹ️ Lecture par le navigateur · voix studio IA bientôt
EU negotiators have reached agreement on new rules designed to address persistent drug shortages that have plagued the European bloc.
The accord includes measures to ease the use of public funds in supporting production of essential medicines, a key mechanism to stabilize supply chains. The agreement reflects growing concern among member states over medication availability across critical therapeutic categories.
The new framework is expected to strengthen pharmaceutical resilience and reduce dependency on external suppliers for vital treatments.